Pengfei Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pengfei Wu has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Xudong Yao
Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
13 shared publications - Wentao Zhang
Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
10 shared publications - Ruiliang Wang
Shanghai Tenth People’s Hospital 1 Department of Urology Tongji University School of Medicine, Shanghai, China
9 shared publications - Fuhan Yang
Shanghai Tenth People’s Hospital 1 Department of Urology Tongji University School of Medicine, Shanghai, China
8 shared publications - Hao-Tian Chen
Shanghai Tenth People’s Hospital 1 Department of Urology Tongji University School of Medicine, Shanghai, China
8 shared publications - Hui-Hui Ma
Clinical Medicine Scientific and Technical Innovation Center, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
8 shared publications
Latest Publications
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
Bladder cancer cells recruit MDSCs during P. aeruginosa infection
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
Bladder cancer cells recruit MDSCs during P. aeruginosa infection
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
P. aeruginosa infection exacerbates bladder cancer progression
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
P. aeruginosa infection exacerbates bladder cancer progression
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Data from Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
Pseudomonas aeruginosa infection is still a serious problem among immunocompromised patients who have advanced urinary tract malignancies, yet the impact of P. aeruginosa on disease progression remains poorly defined. In this study, we show that urinary tract infections caused by P. aeruginosa exacerbated bladder cancer progression in murine models, primarily by inducing an immunosuppressive tumor microenvironment. Mechanistically, P. aeruginosa activated Toll-like receptor 5 (TLR5) on bladder cancer cells, triggering phosphorylation of ERK1/2 and subsequent secretion of the chemokine CCL20. This signaling axis promoted the recruitment of myeloid-derived suppressor cells (MDSC), thereby reinforcing immunosuppression within the tumor microenvironment and exacerbating bladder cancer growth. In clinical samples, 16S rRNA sequencing and transcriptome analysis of bladder cancer tissues confirmed the presence of P. aeruginosa, with its abundance significantly correlating with advanced disease stages and elevated CCL20 expression. Collectively, these data identify a role for P. aeruginosa in promoting bladder cancer progression through TLR5–ERK1/2–CCL20–mediated MDSC recruitment, shedding light on the intricate interplay between microbial infection and cancer pathogenesis. These insights highlight potential therapeutic targets to disrupt infection-driven cancer progression.
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
Pseudomonas aeruginosa infection is still a serious problem among immunocompromised patients who have advanced urinary tract malignancies, yet the impact of P. aeruginosa on disease progression remains poorly defined. In this study, we show that urinary tract infections caused by P. aeruginosa exacerbated bladder cancer progression in murine models, primarily by inducing an immunosuppressive tumor microenvironment. Mechanistically, P. aeruginosa activated Toll-like receptor 5 (TLR5) on bladder cancer cells, triggering phosphorylation of ERK1/2 and subsequent secretion of the chemokine CCL20. This signaling axis promoted the recruitment of myeloid-derived suppressor cells (MDSC), thereby reinforcing immunosuppression within the tumor microenvironment and exacerbating bladder cancer growth. In clinical samples, 16S rRNA sequencing and transcriptome analysis of bladder cancer tissues confirmed the presence of P. aeruginosa, with its abundance significantly correlating with advanced disease stages and elevated CCL20 expression. Collectively, these data identify a role for P. aeruginosa in promoting bladder cancer progression through TLR5–ERK1/2–CCL20–mediated MDSC recruitment, shedding light on the intricate interplay between microbial infection and cancer pathogenesis. These insights highlight potential therapeutic targets to disrupt infection-driven cancer progression.
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
Bladder cancer cells recruit MDSCs during P. aeruginosa infection
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
Bladder cancer cells recruit MDSCs during P. aeruginosa infection
- 9 January 2026
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 14 (3) , 387-398
Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
Pseudomonas aeruginosa infection is still a serious problem among immunocompromised patients who have advanced urinary tract malignancies, yet the impact of P. aeruginosa on disease progression remains poorly defined. In this study, we show that urinary tract infections caused by P. aeruginosa exacerbated bladder cancer progression in murine models, primarily by inducing an immunosuppressive tumor microenvironment. Mechanistically, P. aeruginosa activated Toll-like receptor 5 (TLR5) on bladder cancer cells, triggering phosphorylation of ERK1/2 and subsequent secretion of the chemokine CCL20. This signaling axis promoted the recruitment of myeloid-derived suppressor cells (MDSC), thereby reinforcing immunosuppression within the tumor microenvironment and exacerbating bladder cancer growth. In clinical samples, 16S rRNA sequencing and transcriptome analysis of bladder cancer tissues confirmed the presence of P. aeruginosa, with its abundance significantly correlating with advanced disease stages and elevated CCL20 expression. Collectively, these data identify a role for P. aeruginosa in promoting bladder cancer progression through TLR5–ERK1/2–CCL20–mediated MDSC recruitment, shedding light on the intricate interplay between microbial infection and cancer pathogenesis. These insights highlight potential therapeutic targets to disrupt infection-driven cancer progression.
- 9 January 2026
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 14 (3) , 387-398
Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
Pseudomonas aeruginosa infection is still a serious problem among immunocompromised patients who have advanced urinary tract malignancies, yet the impact of P. aeruginosa on disease progression remains poorly defined. In this study, we show that urinary tract infections caused by P. aeruginosa exacerbated bladder cancer progression in murine models, primarily by inducing an immunosuppressive tumor microenvironment. Mechanistically, P. aeruginosa activated Toll-like receptor 5 (TLR5) on bladder cancer cells, triggering phosphorylation of ERK1/2 and subsequent secretion of the chemokine CCL20. This signaling axis promoted the recruitment of myeloid-derived suppressor cells (MDSC), thereby reinforcing immunosuppression within the tumor microenvironment and exacerbating bladder cancer growth. In clinical samples, 16S rRNA sequencing and transcriptome analysis of bladder cancer tissues confirmed the presence of P. aeruginosa, with its abundance significantly correlating with advanced disease stages and elevated CCL20 expression. Collectively, these data identify a role for P. aeruginosa in promoting bladder cancer progression through TLR5–ERK1/2–CCL20–mediated MDSC recruitment, shedding light on the intricate interplay between microbial infection and cancer pathogenesis. These insights highlight potential therapeutic targets to disrupt infection-driven cancer progression.
- Open Access
- 1 July 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1647090
Correction: Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population
Correction: Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian populationAffiliations of all authors as they appear in the published original version of the article (1Department of Urology, Shanghai Tenth People's Hospital, Clinical Medical College of Nanjing Medical University, Shanghai, China.2Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.3Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, China.4Department of Breast and Thyroid Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.5Shanghai Center of Thyroid Diseases, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.)* Correspondence: yaoxudong1967@163.comKeywords: same as original articleCorrection on: Wang Z, Chen H, Liu Y, Zou L, Zhang Z, Yin Z, Mao S, Guo C, Yang B, Wu P and Yao X (2025) Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population. Front. Oncol. 14:1466190. doi: 10.3389/fonc.2024.1466190 Additional affiliation(s)In the published article, there was an error regarding the affiliation(s) for [Xudong Yao]. As well as having affiliation(s) [2,3], they should also have [Department of Urology, Shanghai Tenth People's Hospital, Clinical Medical College of Nanjing Medical University, Shanghai, China].The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
- 1 July 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1647090
Open AccessCorrection: Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population
Correction: Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian populationAffiliations of all authors as they appear in the published original version of the article (1Department of Urology, Shanghai Tenth People's Hospital, Clinical Medical College of Nanjing Medical University, Shanghai, China.2Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.3Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, China.4Department of Breast and Thyroid Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.5Shanghai Center of Thyroid Diseases, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.)* Correspondence: yaoxudong1967@163.comKeywords: same as original articleCorrection on: Wang Z, Chen H, Liu Y, Zou L, Zhang Z, Yin Z, Mao S, Guo C, Yang B, Wu P and Yao X (2025) Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population. Front. Oncol. 14:1466190. doi: 10.3389/fonc.2024.1466190 Additional affiliation(s)In the published article, there was an error regarding the affiliation(s) for [Xudong Yao]. As well as having affiliation(s) [2,3], they should also have [Department of Urology, Shanghai Tenth People's Hospital, Clinical Medical College of Nanjing Medical University, Shanghai, China].The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
- Open Access
- 14 May 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (5) , 1197
2bRAD-M Reveals the Characteristics of Urinary Microbiota in Overweight Patients with Urinary Tract Stones
Background: Urinary tract stone (UTS) is a common disease significantly impacting human health. Obesity influences stone formation and increases UTS incidence, yet the differences in the urinary microbiota and pathways between overweight and healthy-weight UTS patients remain unclear. Methods: In this study, 16 patients were analyzed: 8 overweight and 8 healthy-weight UTS patients. Bladder urine samples were collected during surgery, and DNA was extracted for microbial analysis using 2bRAD markers. Microbial diversity and KEGG pathway differences were studied. Results: The results showed that overweight UTS patients had a significantly higher urinary microbial diversity than healthy-weight patients. The analysis identified differences in microbiota at various taxonomic levels. LEfSe analysis revealed Sphingomonas_paucimobilis as abundant in overweight patients, while Bifidobacterium_piotii dominated in healthy-weight patients. Key species, including Ralstonia_sp000620465, Sphingomonas_paucimobilis, and Campylobacter_D_coli, were identified. KEGG analysis highlighted enriched pathways in overweight UTS patients, including the porphyrin and chlorophyll metabolism, fatty acid metabolism, amino acid degradation, and renin–angiotensin and mineral absorption pathways. Conclusions: This study is the first to use 2bRAD-M microbiome analysis to compare the urinary microbiota between overweight and healthy-weight UTS patients. It identified significant microbiota and pathway differences, suggesting a link between microbiota imbalance, obesity, and stone formation. These findings provide potential targets for further research on obesity-related stone susceptibility mechanisms.
- 14 May 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (5) , 1197
Open Access2bRAD-M Reveals the Characteristics of Urinary Microbiota in Overweight Patients with Urinary Tract Stones
Background: Urinary tract stone (UTS) is a common disease significantly impacting human health. Obesity influences stone formation and increases UTS incidence, yet the differences in the urinary microbiota and pathways between overweight and healthy-weight UTS patients remain unclear. Methods: In this study, 16 patients were analyzed: 8 overweight and 8 healthy-weight UTS patients. Bladder urine samples were collected during surgery, and DNA was extracted for microbial analysis using 2bRAD markers. Microbial diversity and KEGG pathway differences were studied. Results: The results showed that overweight UTS patients had a significantly higher urinary microbial diversity than healthy-weight patients. The analysis identified differences in microbiota at various taxonomic levels. LEfSe analysis revealed Sphingomonas_paucimobilis as abundant in overweight patients, while Bifidobacterium_piotii dominated in healthy-weight patients. Key species, including Ralstonia_sp000620465, Sphingomonas_paucimobilis, and Campylobacter_D_coli, were identified. KEGG analysis highlighted enriched pathways in overweight UTS patients, including the porphyrin and chlorophyll metabolism, fatty acid metabolism, amino acid degradation, and renin–angiotensin and mineral absorption pathways. Conclusions: This study is the first to use 2bRAD-M microbiome analysis to compare the urinary microbiota between overweight and healthy-weight UTS patients. It identified significant microbiota and pathway differences, suggesting a link between microbiota imbalance, obesity, and stone formation. These findings provide potential targets for further research on obesity-related stone susceptibility mechanisms.